Anbio Biotechnology Class Stock Price Patterns
| NNNN Stock | 24.20 1.03 4.08% |
Momentum 44
Sell Extended
Oversold | Overbought |
Using Anbio Biotechnology hype-based prediction, you can estimate the value of Anbio Biotechnology Class from the perspective of Anbio Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Anbio Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying Anbio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Anbio Biotechnology after-hype prediction price | USD 24.2 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections. Anbio Biotechnology After-Hype Price Density Analysis
As far as predicting the price of Anbio Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anbio Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anbio Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anbio Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Anbio Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anbio Biotechnology's historical news coverage. Anbio Biotechnology's after-hype downside and upside margins for the prediction period are 14.02 and 34.38, respectively. We have considered Anbio Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anbio Biotechnology is slightly risky at this time. Analysis and calculation of next after-hype price of Anbio Biotechnology Class is based on 3 months time horizon.
Anbio Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Anbio Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anbio Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anbio Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 10.18 | 0.00 | 0.03 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
24.20 | 24.20 | 0.00 |
|
Anbio Biotechnology Hype Timeline
Anbio Biotechnology Class is now traded for 24.20. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Anbio is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.36%. %. The volatility of related hype on Anbio Biotechnology is about 11438.2%, with the expected price after the next announcement by competition of 24.23. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be uncertain. Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections.Anbio Biotechnology Related Hype Analysis
Having access to credible news sources related to Anbio Biotechnology's direct competition is more important than ever and may enhance your ability to predict Anbio Biotechnology's future price movements. Getting to know how Anbio Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anbio Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ANGO | AngioDynamics | 0.12 | 10 per month | 0.00 | (0.06) | 4.60 | (4.55) | 18.26 | |
| TALK | Talkspace | 0.09 | 8 per month | 2.64 | 0.05 | 4.35 | (4.72) | 13.51 | |
| CLPT | Clearpoint Neuro | 0.00 | 0 per month | 0.00 | (0.02) | 7.08 | (5.56) | 21.07 | |
| CYH | Community Health Systems | 0.00 | 0 per month | 1.86 | 0.08 | 5.16 | (2.40) | 15.66 | |
| CMPS | Compass Pathways Plc | 0.00 | 0 per month | 3.53 | 0.03 | 8.25 | (5.59) | 21.95 | |
| AVNS | Avanos Medical | (0.28) | 10 per month | 1.48 | 0.16 | 4.68 | (3.03) | 9.85 | |
| KALV | Kalvista Pharmaceuticals | 0.59 | 9 per month | 3.55 | 0.11 | 8.43 | (6.60) | 25.15 | |
| GOSS | Gossamer Bio | 0.37 | 14 per month | 4.83 | (0.01) | 8.77 | (7.10) | 27.11 | |
| RIGL | Rigel Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.12) | 6.18 | (6.40) | 19.03 | |
| SNDL | SNDL Inc | 0.00 | 0 per month | 0.00 | (0.03) | 4.82 | (5.88) | 37.98 |
Anbio Biotechnology Additional Predictive Modules
Most predictive techniques to examine Anbio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anbio using various technical indicators. When you analyze Anbio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Anbio Biotechnology Predictive Indicators
The successful prediction of Anbio Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anbio Biotechnology Class, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anbio Biotechnology based on analysis of Anbio Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anbio Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anbio Biotechnology's related companies.
Pair Trading with Anbio Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anbio Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anbio Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Anbio Stock
| 0.65 | CMB | Cambium Bio | PairCorr |
| 0.63 | AVH | Avita Medical | PairCorr |
| 0.54 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
| 0.51 | PYC | Physiomics Plc | PairCorr |
| 0.46 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.44 | DNLI | Denali Therapeutics | PairCorr |
The ability to find closely correlated positions to Anbio Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anbio Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anbio Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anbio Biotechnology Class to buy it.
The correlation of Anbio Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anbio Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anbio Biotechnology Class moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anbio Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Anbio Biotechnology Basic Forecasting Models to cross-verify your projections. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Will Biotechnology sector continue expanding? Could Anbio diversify its offerings? Factors like these will boost the valuation of Anbio Biotechnology. Anticipated expansion of Anbio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Anbio Biotechnology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Anbio Biotechnology Class requires distinguishing between market price and book value, where the latter reflects Anbio's accounting equity. The concept of intrinsic value - what Anbio Biotechnology's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Anbio Biotechnology's price substantially above or below its fundamental value.
It's important to distinguish between Anbio Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Anbio Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Anbio Biotechnology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.